761 related articles for article (PubMed ID: 10561272)
21. A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors.
Anderlini P; Donato M; Lauppe MJ; Huh YO; Martin TG; Chan KW; Champlin RE; Körbling M
Br J Haematol; 2000 Jun; 109(4):770-2. PubMed ID: 10929027
[TBL] [Abstract][Full Text] [Related]
22. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
Cavallaro AM; Lilleby K; Majolino I; Storb R; Appelbaum FR; Rowley SD; Bensinger WI
Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience.
Anderlini P; Donato M; Chan KW; Huh YO; Gee AP; Lauppe MJ; Champlin RE; Körbling M
Transfusion; 1999 Jun; 39(6):555-60. PubMed ID: 10378833
[TBL] [Abstract][Full Text] [Related]
24. Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study.
Beelen DW; Ottinger H; Kolbe K; Pönisch W; Sayer HG; Knauf W; Stockschläder M; Scheid C; Schaefer UW
Ann Hematol; 2002 Dec; 81(12):701-9. PubMed ID: 12483366
[TBL] [Abstract][Full Text] [Related]
25. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
[TBL] [Abstract][Full Text] [Related]
26. Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy.
Waller CF; von Lintig F; Daskalakis A; Musahl V; Lange W
Bone Marrow Transplant; 1999 Jul; 24(1):19-24. PubMed ID: 10435729
[TBL] [Abstract][Full Text] [Related]
27. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
Bone Marrow Transplant; 1996 Dec; 18(6):1073-9. PubMed ID: 8971375
[TBL] [Abstract][Full Text] [Related]
28. Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients.
Meehan KR; Slack R; Gehan E; Herscowitz HB; Areman EM; Ebadi M; Cairo MS; Lippman ME
J Hematother Stem Cell Res; 2002 Apr; 11(2):415-21. PubMed ID: 11983113
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
Körbling M; Huh YO; Durett A; Mirza N; Miller P; Engel H; Anderlini P; van Besien K; Andreeff M; Przepiorka D; Deisseroth AB; Champlin RE
Blood; 1995 Oct; 86(7):2842-8. PubMed ID: 7545476
[TBL] [Abstract][Full Text] [Related]
30. Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study.
Basara N; Schmetzer B; Blau IW; Bischoff M; Günzelmann S; Kirsten D; Fauser AA
Bone Marrow Transplant; 2000 Feb; 25(4):371-6. PubMed ID: 10723579
[TBL] [Abstract][Full Text] [Related]
31. Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields.
De la Rubia J; Arbona C; Del Cañizo C; Arrieta R; De Arriba F; Pascual MJ; Sanjuan I; Díaz MA; Brunet S; Alegre A; Insunza A; Espigado I; Zamora C; De la Serna J; Serrano D; Bargay J; Petit J; Martínez D; Verdeguer A; Ribera JM; Martínez C; Benlloch L; Sanz MA
J Hematother Stem Cell Res; 2002 Aug; 11(4):705-9. PubMed ID: 12201959
[TBL] [Abstract][Full Text] [Related]
32. Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors.
Körbling M; Chan KW; Anderlini P; Seong D; Durett A; Langlinais A; Przepiorka D; Gajewski J; Miller P; Sundberg J; Alilaen P; Bojko P; Mirza N; Claxton D; van Besien K; Khouri I; Andersson B; Mehra R; Champlin R
Bone Marrow Transplant; 1996 Nov; 18(5):885-90. PubMed ID: 8932841
[TBL] [Abstract][Full Text] [Related]
33. Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.
van Oostrum A; Zwaginga JJ; Croockewit S; Overdevest J; Fechter M; Ruiterkamp B; Brand A; Netelenbos T
J Clin Apher; 2017 Dec; 32(6):397-404. PubMed ID: 28139098
[TBL] [Abstract][Full Text] [Related]
34. Mobilization and collection of allogeneic peripheral blood progenitor cells for transplantation.
Wiesneth M; Schreiner T; Friedrich W; Bunjes D; Duncker C; Krug E; Maccari B; Müller S; Nowak S; Kubanek B
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S21-4. PubMed ID: 9712487
[TBL] [Abstract][Full Text] [Related]
35. Single vs twice daily G-CSF dose for peripheral blood stem cells harvest in normal donors and children with non-malignant diseases.
Lee V; Li CK; Shing MM; Chik KW; Li K; Tsang KS; Zhao DC; Lai DH; Wong A; Yuen PM
Bone Marrow Transplant; 2000 May; 25(9):931-5. PubMed ID: 10800059
[TBL] [Abstract][Full Text] [Related]
36. Treatment of normal donors with rhG-CSF 16 micrograms/kg for mobilization of peripheral blood stem cells and their apheretic collection for allogeneic transplantation.
Majolino I; Buscemi F; Scimé R; Indovina A; Santoro A; Vasta S; Pampinella M; Catania P; Fiandaca T; Caronia F
Haematologica; 1995; 80(3):219-26. PubMed ID: 7545635
[TBL] [Abstract][Full Text] [Related]
37. Mobilization of hematopoietic progenitor stem cells in allogeneic setting with lenograstim by subcutaneous injection, in daily or twice-daily dosing: a single-center prospective study with historical control.
Martino M; Moscato T; Barillà S; Dattola A; Pontari A; Fedele R; Furlò G; Marzia Stilo C; Alberto Gallo G; Tripepi G
Transfusion; 2015 Aug; 55(8):2032-8. PubMed ID: 25857853
[TBL] [Abstract][Full Text] [Related]
38. Collection of peripheral blood progenitor cells on Day 4 is feasible and effective while reducing granulocyte-colony-stimulating factor exposure to healthy donors.
Flommersfeld S; Sohlbach K; Jaques G; Bein G; Hoffmann J; Kostrewa P; Sachs UJ
Transfusion; 2015 Jun; 55(6):1269-74. PubMed ID: 25647638
[TBL] [Abstract][Full Text] [Related]
39. Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factor.
Basser RL; To LB; Begley CG; Maher D; Juttner C; Cebon J; Mansfield R; Olver I; Duggan G; Szer J; Collins J; Schwartz B; Marty J; Menchaca D; Sheridan WP; Fox RM; Green MD
J Clin Oncol; 1998 May; 16(5):1899-908. PubMed ID: 9586908
[TBL] [Abstract][Full Text] [Related]
40. Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery.
Faucher C; Le Corroller AG; Chabannon C; Viens P; Stoppa AM; Bouabdallah R; Camerlo J; Vey N; Gravis G; Gastaut JA; Novakovitch G; Mannoni P; Bardou VJ; Moatti JP; Maraninchi D; Blaise D
J Hematother; 1996 Dec; 5(6):663-70. PubMed ID: 9117255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
